The role of CRH in behavioral responses to stress

Peptides

Volumn 22, Issue 5, 2001, Pages 713-724

  Smagin, Gennady N ^a   Heinrichs, Stephen C ^b   Dunn, Adrian J ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

Antagonists; Antisense; Behavior; Corticotropin releasing factor; CRH receptors; Stress; Urocortin

Indexed keywords

4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; 5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; ANTALARMIN; ANTISAUVAGINE 30; ANTISENSE OLIGONUCLEOTIDE; ASTRESSIN; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[12-41](DEXTRO PHENYLALANINE); CORTICOTROPIN RELEASING FACTOR[9-41]; HORMONE RECEPTOR STIMULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 1BETA; RECEPTOR SUBTYPE; SAUVAGINE; UNCLASSIFIED DRUG; UROCORTIN; UROTENSIN;

ARTICLE; BEHAVIOR; BINDING AFFINITY; BINDING SITE; BRAIN; DRUG EFFECT; DRUG RECEPTOR BINDING; FEEDING BEHAVIOR; HUMAN; NONHUMAN; PRIORITY JOURNAL; STRESS; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PSYCHOLOGICAL;

EID: 0035032628     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00384-9     Document Type: Article

References (91)

1. The role of corticotropin-releasing factor in depression and anxiety disorders
2. Neurobiology of corticotropin-releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders
3. Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression
4. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice
5. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice
6. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors
7. A comparison of the behavioral effects of CRF, sauvagine and urotensin I
8. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat
9. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role
10. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression
11. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain
12. Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor-1 receptor antagonists
13. Expression cloning of a human corticotropin-releasing-factor receptor
14. Amygdala and bed nucleus of the stria terminalis: Differential roles in fear and anxiety measured with the acoustic startle reflex
15. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
16. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
17. The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats
18. Cloning and characterization of human urocortin
19. Is corticotropin-releasing factor a mediator of stress responses?
20. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses?
21. Behavioral responses to stress are intact in CRF-deficient mice
22. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake
23. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor
24. Increase of urocortin-like immunoreactivity in the rat hypothalamo-neurohypophysial system after salt loading and hypophysectomy
25. Increase of urocortin-like immunoreactivity in the supraoptic nucleus of Dahl rats given a high salt diet
26. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats
27. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior
28. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity
29. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior
30. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
31. Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats
32. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal
33. The behavioral effects of corticotropin-releasing factor-related peptides in rats
34. Urocortin messenger ribonucleic acid: Tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids
35. Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys
36. Corticotropin-releasing factor, norepinephrine, and stress
37. Corticotropin-releasing factor and behavior
38. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
39. 2 gamma receptor
40. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat
41. Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats
42. Differential behavioral effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain
43. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates
44. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
45. CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues
46. Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure
47. 1 receptor antagonist
48. Corticotropin-releasing factor but not urocortin is involved in adrenalectomy-induced adrenocorticotropin release
49. Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord
50. Corticotropin releasing factor (CRF): Origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus
51. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain
52. Urocortin, a novel neuropeptide with anxiogenic-like properties
53. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain
54. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001
55. Physiology and pharmacology of corticotropin-releasing factor
56. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor
57. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary
58. CRF and CRF receptors
59. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
60. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system
61. Synthetic competitive antagonists of corticotropin-releasing factor: Effect on ACTH secretion in the rat
62. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2beta-selective antisauvagine-30
63. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method
64. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman brain
65. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain
66. Organization of CRF immunoreactive cells and fibers in the rat brain: Immunohistochemical studies
67. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
68. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats
69. The effects of ICV-CRH on novelty-induced behavior
70. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response and aberrant neuroendocrine development
71. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
72. Corticotropin-releasing hormone receptor subtypes and emotion
73. Corticotropin releasing factor produces behavioural activation in rats
74. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study
75. CRF-deficient mice respond like wild-type mice to hypophagic stimuli
76. Role of corticotropin-releasing factor in mediating the expression of defensive behavior
77. Corticotropin-releasing factor modulates defensive withdrawal and exploratory behavior in rats
78. Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats
79. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
80. Corticotropin-releasing factor (CRF) and endocrine response to stress: CRF receptors, binding protein, and related peptides
81. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat
82. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
83. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
84. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation
85. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
86. CRH-deficient mice have a normal anorectic response to chronic stress
87. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency
88. Localization of urocortin messenger RNA in rat brain and pituitary
89. Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat
90. The distribution of urocortin-like immunoreactivity in the central nervous system of the rat